Search Tag: drug development

IT Management

Machine Learning and COVID-19 Management

2021 14 Jan

A new systematic review (Syeda et al. 2021) analyses artificial intelligence (AI) -based methods utilised to tackle the pandemic and provides insights into different COVID-19 themes.   You might also like: AI Tool Helps to Reduce COVID-19 Mortality   Since the onset of the COVID-19 pandemic, many healthcare organisations have... Read more

Cardiology Management

Dr Nader N Youssef appointed Chief Medical Officer of electroCore

2015 06 Aug

6th August 2015, Basking Ridge, New Jersey; Dr Nader N Youssef, has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore.   He was previously Executive Director GI Global Clinical Development and... Read more

Cardiology Management

Simplified Clinical Trials to Sustain Innovation

2015 18 Jun

According to the Cardiovascular Round Table (CRT), randomised controlled trials must be simplified to sustain innovation in cardiovascular diseases. CRT is an independent forum established by the European Society of Cardiology (ESC). The views of the group are published in the European Heart Journal . Professor Paulus Kirchhof, corresponding author,... Read more

Pharmacy Management

New Screening Method May Identify Drug Toxicity

2015 11 Feb

A group of researchers from Weill Cornell Medical College in New York City have devised a drug screen that capitalises on the tendency of toxic compounds to alter the properties of the lipid bilayer that encases cells. The method is to be presented at the 59th annual meeting of the Biophysical Society. As far as drug development is concerned,... Read more

Health Management

Psychiatric Drug Development – A Dry Pipeline?

2014 08 Nov

Key Points • Psychiatric drugs are among the most profitable products for the pharmaceutical industry. • Despite this, investment in psychiatric drug development continues to decline. • A major reason may be the fact that there has been no major breakthrough in this area of drug development for the last thirty years. • Several “me-too” products have... Read more

Pharmacy Management

Biosimilars: Billions in Sales and Savings by 2020

2014 01 Oct

According to new research from Thomson Reuters Bioworld, there are more than 700 follow-on biologic therapies currently in development. The new therapies are expected to generate approximately $100 billion in sales by the end of this decade. These projections demonstrate that the biopharmaceutical development industry is rapidly growing with... Read more